Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derralynn A Hughes

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in Cardiology|May 21, 2016
Fabry disease: will markers of early disease enable early treatment and better outcomes?Derralynn A Hughes
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 25, 2006
The use of scoring systems in patients with haematological malignancyDerralynn A Hughes
American Journal of Hematology|March 18, 2009
Enzyme, substrate, and myeloma in Gaucher diseaseDerralynn A Hughes
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Early therapeutic intervention in females with Fabry disease?Derralynn A Hughes
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease and myelomaRobert Ayto, Derralynn A Hughes
Journal of Nephrology|March 21, 2020
New drugs for the treatment of Anderson-Fabry diseaseSandro Feriozzi, Derralynn A Hughes
European Journal of Haematology|January 11, 2024
Soluble mannose receptor: A potential biomarker in Gaucher diseaseBrendan Beaton, Derralynn A Hughes
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatmentsGregory M Pastores, Derralynn A Hughes
Wiener Medizinische Wochenschrift (1946)|January 12, 2011
The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approachesDerralynn A Hughes, Gregory M Pastores
Journal of Inherited Metabolic Disease|June 16, 2010
Editorial overview: lysosomal storage disorders with primary neurological involvementGregory M Pastores, Derralynn A Hughes
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Cardiology|May 21, 2016
Fabry disease: will markers of early disease enable early treatment and better outcomes?Derralynn A Hughes
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 25, 2006
The use of scoring systems in patients with haematological malignancyDerralynn A Hughes
American Journal of Hematology|March 18, 2009
Enzyme, substrate, and myeloma in Gaucher diseaseDerralynn A Hughes
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Early therapeutic intervention in females with Fabry disease?Derralynn A Hughes
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease and myelomaRobert Ayto, Derralynn A Hughes
Journal of Nephrology|March 21, 2020
New drugs for the treatment of Anderson-Fabry diseaseSandro Feriozzi, Derralynn A Hughes
European Journal of Haematology|January 11, 2024
Soluble mannose receptor: A potential biomarker in Gaucher diseaseBrendan Beaton, Derralynn A Hughes
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatmentsGregory M Pastores, Derralynn A Hughes
Wiener Medizinische Wochenschrift (1946)|January 12, 2011
The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approachesDerralynn A Hughes, Gregory M Pastores
Journal of Inherited Metabolic Disease|June 16, 2010
Editorial overview: lysosomal storage disorders with primary neurological involvementGregory M Pastores, Derralynn A Hughes
Pageof 10